ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,772, issued on April 14, was assigned to Motokazu Kato (Osaka, Japan).
"Therapeutic agent for asthma containing IL-6 inhibitor" was invented by Motokazu Kato (Osaka, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides therapeutic agents for treating human asthma through administration of an IL-6 inhibitor to humans. Representative IL-6 inhibitors in the present invention include IL-6 receptor antibodies and IL-6 antibodies. Therapeutic agents of the present invention can yield therapeutic effects in severe asthma patients who need administration of high-dose steroids and such for alleviation of symptoms, or even in p...